Fructose and related phosphate derivatives impose DNA damage and apoptosis in L5178Y mouse lymphoma cells

Journal of Nutritional Biochemistry

Volumn 14, Issue 1, 2003, Pages 49-60

  Levi, Boaz ^a   Werman, Moshe J ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Apoptosis; Cytotoxicity; DNA; Fructose; Glycation; Mutation

Indexed keywords

AMINOGUANIDINE; DNA; FRUCTOSE; FRUCTOSE 1 PHOSPHATE; GLUCOSE 1 PHOSPHATE; GLUCOSE 6 PHOSPHATE; PHOSPHATE; SUCROSE; THYMIDINE KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CELL LINE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; DNA DAMAGE; DNA MODIFICATION; GLYCATION; LYMPHOMA CELL; MOUSE; NONHUMAN; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; DNA DAMAGE; DNA FRAGMENTATION; FRUCTOSE; LEUKEMIA L5178; MICE; PHOSPHATES; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0037260162     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(02)00254-1     Document Type: Article

References (61)

1. Monnier V.M. Toward a Maillard reaction theory of aging. Baynes, Monnier. The Maillard Reaction in Aging, Diabetes, and Nutrition. 1989;1-22 Alan R. Liss, Inc, New York, NY.
2. Olff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of autoxidative glycosylation in diabetes. Biochem J. 245:1987;243-250.
3. Harding J. Nonenzymatic covalent posttranslational modification of proteins in vivo. Adv Protein Chem. 37:1985;247-334.
4. Cerami A., Vlassara H., Brownlee M. Role of nonenzymatic glycosylation in atherogenesis. J Cell Biochem. 30:1986;111-120.
5. Yaylayan V.A., Huyghues D.A. Chemistry of Amadori rearrangement products analysis, synthesis, kinetics, reactions, and spectroscopic properties . Crit Rev Food Sci Nutr. 34:1994;321-369.
6. Monnier V.M. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J Gerontol. 45:1990;8105-8111.
7. Fu M.X., Wells-Knecht K.J., Blackledge J.A., Lyons T.J., Thorpe S.R., Baynes J.W. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes. 43:1994;676-683.
8. Vlassara H. Recent progress on the biologic and clinic significance of advanced glycosylation end products. J Lab Clin Med. 124:1994;19-30.
9. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
10. Bucala R., Cerami A. Advanced glycosylation chemistry, biology, and implications for diabetes and aging . Adv Pharmacol. 23:1992;1-34.
11. Van Boekel M.A.M. The role of glycation in aging and diabetes mellitus. Mol Biol Reports. 15:1991;57-64.
12. Sell D.R., Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem. 1989;21597-21602.
13. Stadtman E.R. Covalent modification reactions are marking steps in protein turnover. Biochemistry. 10:1990;6323-6331.
14. Masoro E.J. Biology of aging facts, thoughts, and experimental approaches . Lab Invest. 65:1991;500-510.
15. Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation biochemical, biologic, and clinical implications for diabetes and aging . Lab Invest. 70:1994;138-151.
16. Dyrks T., Dyrks E., Hartmann T., Masters C., Beyreuther K. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem. 267:1992;18210-18217.
17. Vitek M.P., Bhattacharya K., Glendening J.M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA. 91:1994;4766-4770.
18. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.D., Stern D., Sayre L.M., Monnier V.M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA. 91:1994;5710-5714.
19. Monnier V.M., Cerami A. Nonenzymatic browning in vivo possible process for aging of long-lived proteins . Science. 211:1981;491-493.
20. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med. 101:1984;527-537.
21. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Eng J Med. 318:1988;1315-1321.
22. Bucala R., Model P., Cerami A. Modification of DNA by reducing sugars A possible mechanism for nucleic acid and age-related dysfunction in gene expression . Proc Natl Acad Sci USA. 81:1984;105-109.
23. Morita J., Kashimura N. The Maillard reaction of DNA with D-fructose 6-phosphate. Agric Biol Chem. 55:1991;1359-1366.
24. Bucala R., Model P., Russel M., Cerami A. Modification of DNA by glucose 6-phosphate induces DNA rearrangements in an Escherichia coli plasmid. Proc Natl Acad Sci USA. 1985;8439-8442.
25. Mullokandov E.A., Franklin W.A., Brownlee M. DNA damage by the glycation products of glyceraldehyde 3-phosphate and lysine. Diabetologia. 1994;145-149.
26. Lee A.T., Cerami A. Elevated glucose 6-phosphate levels are associated with plasmid mutation in vivo. Proc Natl Acad Sci USA. 84:1987;8311-8314.
27. Ortwerth B.J., Feather M.S., Olesen P.R. The precipitation and cross-linking of lens crystallins by ascorbic acid. Exp Eye Res. 47:1988;155-168.
28. Bunn H.F., Higgins P.L. Reaction of monosaccharides with proteins possible evolutionary significance . Science. 1981;222-224.
29. McPherson J.D., Shilton B.H., Walton D.J. Role of fructose glycation and cross-linking of proteins. Biochemistry. 27:1988;1901-1907.
30. Suarez G., Rajaram R., Oronsky A.L., Gaxinowicz M.A. Nonenzymatic glycation of bovine serum albumin by fructose (fructation). Comparison with the Maillard reaction initiated by glucose. J Biol Chem. 264:1989;3674-3679.
31. Gabbay K.H. The sorbitol pathway and the complications of diabetes. N Engl J Med. 288:1973;831-836.
32. Jedziniak J.A., Chylack L.T., Cheng H.M., Gillis M.K., Kalustian A.A., Tung W.H. The sorbitol pathway in the human lens aldose reductase and polyol dehydrogenase . Invest Ophthalmol Vis Sci. 20:1981;314-326.
33. Mayhew J.A., Gillon K.R.W., Hawthorn J.N. Free and lipid inositol, sorbitol and sugars in sciatic nerve obtained postmortem from diabetic patients and control subjects. Diabetologia. 1983;13-15.
34. Gerrits P.M., Tsalikian E. Diabetes and fructose metabolism. Am J Clin Nutr. 58:1993;796S-799S.
35. Park Y.K., Yetley E.A. Intakes of food sources of fructose in the United States. Am J Clin Nutr. 58:1993;737S-747S.
36. Hers H.G. Fructokinase of the liver. Biochim Biophys Acta. 8:1952;416-423.
37. Levi B., Werman M.J. Long-term fructose consumption accelerates glycation and several age-related variables in male rats. J Nutr. 128:1998;1442-1449.
38. Levi B., Werman M.J. Fructose triggers DNA modification and damage in an Escherichia Coli plasmid. J Nutr Biochem. 12:2001;235-241.
39. Romijn C.F., Verkoelen C.F., Schroeder F.H. Application of the MTT assay to human prostate cancer cell lines in vitro establishment of test conditions and assessment of hormone stimulated growth and drug-induced cytostatic and cytotoxic effects . Prostate. 12:1988;99-110.
40. Clive D., Spector J.F. Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutation Res. 31:1975;17-29.
41. Kochi S.K., Collier R.J. DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp Cell Res. 208:1993;296-302.
42. Wyllie A.H., Kerr J.F., Currie A.R. Cell death the significance of apoptosis . Int Rev Cytol. 68:1980;251-306.
43. Zhu N., Wang Z. An assay for DNA fragmentation in apoptosis without phenol chloroform extraction and ethanol precipitation. Anal Biochem. 246:1997;155-158.
44. Swamy M.S., Tsai C., Abraham A., Abraham E.C. Glycation mediated lens crystalline aggregation and cross-linking by various sugars and sugars phosphates in vitro. Exp Eye Res. 56:1993;177-185.
45. Zhao W., Devamanoharan P.S., Varma S. Fructose induce deactivation of glucose 6-phosphate dehydrogenase and its prevention by pyruvate implications in cataract prevention . Free Radic Res. 29:1998;315-320.
46. Thornalley P., Wolff S., Crabbe J., Stern A. The autoxidation of glyceraldehyde and other simple monosaccarides under physiological conditions catalyzed by buffer ions. Biochim Biophys Acta. 797:1984;267-287.
47. Azevedo M., Flacao J., Raposo J., Manso C. Superoxide radical generation by Amadori compounds. Free Radic Res Comm. 4:1998;331-335.
48. Mullarkey M.A., Edelstein D., Brownlee M. Free radical generation by early glycation products A mechanism for accelerated atherogenesis in diabetes . Biochem Biophys Res Comm. 173:1990;932-939.
49. Hunt J.V., Dean R., Wolff P. Hydroxyl radical production and autoxidative glycosylation. Biochem J. 256:1988;205-212.
50. Chace K.V., Carubelli R., Norquist R.E. The role of nonenzymatic glycosylation, transition matels, and free radicals in the formation of collagen aggregates. Arch Biochem Biophys. 288:1991;473-480.
51. Carubelli R., Schneider J.E., Pye Q.N., Floyd R.D. Cytotoxic effects of autoxidative glycation. Free Radic Biol Med. 18:1995;265-269.
52. Barbieri D., Grassilli E., Monti D., et al. D-ribose and deoxy-D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells. Biochem Biophys Res Comm. 201:1994;109-116.
53. Kaneto H., Fujii J., Myint T., et al. Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through glycation reaction. Biochem J. 320:1996;855-863.
54. Chevion M.A. A site-specific mechanism for free radical induce biological damage The essential role of redox-active transition metals . Free Radic Biol Med. 5:1988;27-37.
55. Edelstein D., Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes. 41:1992;26-29.
56. Picard S., Parthasarathy S., Fruebis J., Witztum J.L. Aminoguanidine inhibits oxidative modification of low-density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors. Proc Natl Acad Sci USA. 89:1992;6876-6880.
57. Scaccini C., Chiesa G., Jialal I. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL evidence form interference with some assays of lipoprotein oxidation by aminoguanidine . J Lipid Res. 35:1994;1085-1092.
58. Gould G.W., Thomas H.M., Jess T.J., Bell G.I. Expression of human glucose transporters in Xenopus oocytes kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms . Biochemistry. 30:1991;5139-5145.
59. Mayes P.A. Intermediary metabolism of fructose. Am J Clin Nutr. 58:1993;754S-765S.
60. Swamy M.S., Tsai C., Abraham A., Abraham E.C. Glycation mediated lens crystalline aggregation and cross-linking by various sugars and sugars phosphates in vitro. Exp Eye Res. 1993;177-185.
61. Lal S., Randall W.C., Taylor A.H., Kappler F., Walker M., Brown T.R., Szwergold B.S. Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts. Metabolism. 46:1997;1333-1338.